Article

Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: phenotypes, endotypes and management with desensitization.

2023-08-16

Abstract excerpt

<h4>Background: </h4> Drug hypersensitivity reactions (DHRs) to platinum-based drugs are heterogenous and restrict their access, and drug desensitization (DD) has provided a ground-breaking procedure for their re-introduction, although the response is heterogeneous. We aimed to identify the phenotypes, endotypes and biomarkers of reactions to carboplatin and oxaliplatin and their response to DD. <h4>Methods: </h4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0fce275a-ab0a-5531-ba70-36c4cc54d885
DOI: 10.22541/au.169215785.51427470/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: phenotypes, endotypes and management with desensitization.DOI 10.22541/au.169215785.51427470/v1Read

Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.Semantic proximity Read

From acute phase mediators to drug provocation testing: a single center experience in the allergy work-up of adverse drug reactions to chemotherapySemantic proximity Read

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.Semantic proximity Read

Clinical characteristics and genetic HLA marker for patients with oxaliplatin-induced adverse drug reactions.Semantic proximity Read

Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization ProtocolsSemantic proximity Read

Drug hypersensitivity in the fast lane: What clinicians should know about phenotypes, endotypes, and biomarkers.Semantic proximity Read

The Increasing Role of the Allergist in the Management of Infusion Reactions at the Oncology Day HospitalSemantic proximity Read

Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.Semantic proximity Read

Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms.Semantic proximity Read

Management of adverse reactions to biologic agents.Semantic proximity Read

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.Semantic proximity Read

Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.Semantic proximity Read